Actively Recruiting
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2023-02-16
150
Participants Needed
1
Research Sites
543 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study aims to observe and evaluate the efficacy and safety of a liposomal doxorubicin containing regimen in the postoperative adjuvant treatment of breast cancer patients.
CONDITIONS
Official Title
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female, aged 18-75 years
- Histopathologically diagnosed primary breast cancer
- Adjuvant chemotherapy regimen includes liposomal doxorubicin
- Eastern Cooperative Oncology Group Performance Status (ECoG PS) score of 0-1
- Left ventricular ejection fraction (LVEF) of 55% or higher
- Estimated survival of 6 months or more
- Normal major organ function with white blood cells 4.0 x 10 9 /L, neutrophil count (ANC) 1.5 x 10 9 /L, platelets 100 x 10 9 /L, hemoglobin 10 g/dl, serum creatinine 1.5 times the upper limit of normal (ULN), AST 2.5 times ULN, ALT 2.5 times ULN, and total bilirubin 1.5 times ULN
- Willingness to voluntarily join the study, sign informed consent, have good compliance, and cooperate with follow-up
You will not qualify if you...
- Pregnant or lactating patients
- Breast cancer with distant metastasis
- Peripheral nervous system disorders or history of significant mental and central nervous system disorders
- Severe infection or active peptic ulcer requiring treatment
- Allergy to chemotherapy drugs
- Cancer-free period less than 5 years except for cured basal cell carcinoma of the skin and cured carcinoma in situ of the cervix
- Severe liver disease (e.g., cirrhosis), renal disease, respiratory disease, or uncontrolled diabetes
- Participation in other clinical trials or within one month
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Second Affiliate Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
X
Xiaochen Wang, Dr.
CONTACT
S
Shizhen Zhang, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here